How implementing diagnostic-related grouping (DRG) payment affected the use of opioids and psychotropics by hip fracture patients following hospitalization remained unknown.
A retrospective, pre-post design, cohort study of data excerpted from Taiwan’s National Health Insurance Research database (NHIRD).
Setting and participants
Adults aged ≥ 65 years first admitted for hip fracture surgery from 2007 to 2012 were identified and divided into two 1:1 propensity-score matched groups: pre-DRG (2007–2009); DRG (2010–2012).
The outcome measures were use of opioid and/or psychotropic drugs within 30 days, 90 days, 180 days, and 365 days after discharge.
Data of 16,522 subjects were excerpted, and 8,261 propensity-score matched subjects each classified into the pre-DRG and DRG groups. After adjustment, the DRG group was significantly more likely than the pre-DRG group to have used antipsychotics after discharge from hip fracture surgery (≤30 days, ≤90 days, ≤180 days and ≤365 days). The DRG group also had significantly higher prescription rates of benzodiazepines and antipsychotics during the observation period. Moreover, the DRG group was less likely to use non-steroidal anti-inflammatory drugs (≤30 days, ≤90 days, ≤180 days and ≤365 days) and more likely to use acetaminophen (≤30 days, ≤180 days, and ≤365 days).
In conclusion, DRG implementation in Taiwan substantially increased post-acute prescription of antipsychotic and psychotropic agents for hip fracture patients, and changed use of analgesics, which may result in suboptimal quality and safety for these patients. Further research is needed to evaluate the long-term outcomes of DRG implementation, and the potential benefits of appropriate post-acute care bundled with DRG payment.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Hannan EL, Magaziner J, Wang JJ, et al. Mortality and locomotion 6 months after hospitalization for hip fracture: risk factors and risk-adjusted hospital outcomes. JAMA 2001;285:2736–42.
Nevitt MC, Cummings SR, Kidd S, et al. Risk factors for recurrent nonsyncopal falls. A prospective study. JAMA 1989;261:2663–8.
Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med 1991;324:1326–31.
Marks R, Allegrante JP, Ronald MacKenzie C, et al. Hip fractures among the elderly: causes, consequences and control. Ageing Res Rev 2003;2:57–93.
Fitzgerald JF, Moore PS, Dittus RS. The care of elderly patients with hip fracture. Changes since implementation of the prospective payment system. N Engl J Med 1988;319:1392–7.
Kahn KL, Keeler EB, Sherwood MJ, et al. Comparing outcomes of care before and after implementation of the DRG-based prospective payment system. JAMA 1990;264:1984–8.
Gilman BH. Hospital response to DRG refinements: the impact of multiple reimbursement incentives on inpatient length of stay. Health Econ 2000;9:277–94.
Cheng SH, Chen CC, Tsai SL. The impacts of DRG-based payments on health care provider behaviors under a universal coverage system: a population-based study. Health Policy 2012; 107:202–8.
Kim SJ, Han KT, Kim W, et al. Early Impact on Outpatients of Mandatory Adoption of the Diagnosis-Related Group-Based Reimbursement System in Korea on Use of Outpatient Care: Differences in Medical Utilization and Presurgery Examination. Health Serv Res 2018;53:2064–83.
Hu WY, Yeh CF, Shiao AS, et al. Effects of diagnosis-related group payment on health-care provider behaviors: A consecutive three-period study. J Chin Med Assoc 2015;78:678–85.
Chiou JH, Liu LK, Lee WJ, et al. What factors mediate the inter-relationship between frailty and pain in cognitively and functionally sound older adults. A prospective longitudinal ageing cohort study in Taiwan. BMJ Open 2018;8:e018716.
Brauer C, Morrison RS, Silberzweig SB, et al. The cause of delirium in patients with hip fracture. Arch Intern Med 2000; 160:1856–60.
Eslami V, Zimmerman ME, Grewal T, et al. Pain grade and sleep disturbance in older adults: evaluation the role of pain, and stress for depressed and non-depressed individuals. Int J Geriatr Psychiatry 2016;31:450–7.
Morrison RS, Magaziner J, Gilbert M, et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci 2003;58:76–81.
McGilton KS, Chu CH, Naglie G, et al. Factors Influencing Outcomes of Older Adults After Undergoing Rehabilitation for Hip Fracture. J Am Geriatr Soc 2016;64:1601–9.
Mercadante S, Ferrera P, Villari P, et al. Opioid escalation in patients with cancer pain: the effect of age. J Pain Symptom Manage 2006;32:413–9.
Marcantonio ER, Juarez G, Goldman L, et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994;272:1518–22.
Morrison RS, Magaziner J, McLaughlin MA, et al. The impact of post-operative pain on outcomes following hip fracture. Pain 2003;103:303–11.
Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000; 160:786–94.
Nurminen J, Puustinen J, Piirtola M, et al. Opioids, antiepileptic and anticholinergic drugs and the risk of fractures in patients 65 years of age and older: a prospective population-based study. Age Ageing 2013;42:318–24.
Wagner AK, Zhang F, Soumerai SB, et al. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk. Arch Intern Med 2004; 164:1567–72.
Hugenholtz GW, Heerdink ER, van Staa TP, et al. Risk of hip/femur fractures in patients using antipsychotics. Bone 2005;37:864–70.
Lönnroos E, Kautiainen H, Karppi P, et al. Incidence of second hip fractures. A population-based study. Osteoporos Int 2007;18:1279–85.
Ganz DA, Huang C, Saliba D, et al. Preventing falls in hospitals: a toolkit for improving quality of care. (Prepared by RAND Corporation, Boston University School of Public Health, and ECRI Institute under Contract No. HHSA290201000017I TO #1.) Rockville, MD: Agency for Healthcare Research and Quality; January 2013. AHRQ Publication No. 13-0015-EF. Available at: https://www.ahrq.gov/sites/default/files/publications/files/fallpxtoolkit.pdf [Accessed March 2019].
Baranzini F, Poloni N, Diurni M, et al. [Polypharmacy and psychotropic drugs as risk factors for falls in long-term care setting for elderly patients in Lombardy]. Recenti Prog Med 2009;100:9–16.
Lai SW, Liao KF, Liao CC, et al. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore) 2010;89:295–9.
Hsiao FY, Yang CL, Huang YT, et al. Using Taiwan’s National Health Insurance Research Databases for Pharmacoepidemiology Research. J Food Drug Anal 2007;15:99–108.
Siu AL, Boockvar KS, Penrod JD, et al. Effect of inpatient quality of care on functional outcomes in patients with hip fracture. Med Care 2006;44:862–9.
Givens JL, Sanft TB, Marcantonio ER. Functional recovery after hip fracture: the combined effects of depressive symptoms, cognitive impairment, and delirium. J Am Geriatr Soc 2008;56:1075–9.
Bitsch M, Foss N, Kristensen B, et al. Pathogenesis of and management strategies for postoperative delirium after hip fracture: a review. Acta Orthop Scand 2004;75:378–89.
O’Keeffe ST, Ní Chonchubhair A. Postoperative delirium in the elderly. Br J Anaesth 1994;73:673–87.
Dyer CB, Ashton CM, Teasdale TA. Postoperative delirium. A review of 80 primary data-collection studies. Arch Intern Med 1995; 155:461–5.
Bitsch MS, Foss NB, Kristensen BB, et al. Acute cognitive dysfunction after hip fracture: frequency and risk factors in an optimized, multimodal, rehabilitation program. Acta Anaesthesiol Scand 2006;50:428–36.
Donnelly K, Bracchi R, Hewitt J, et al. Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis. PLoS One 2017; 12:e0174730.
Neutel CI, Hirdes JP, Maxwell CJ, et al. New evidence on benzodiazepine use and falls: the time factor. Age Ageing 1996;25:273–8.
Fraser LA, Liu K, Naylor KL, et al. Falls and fractures with atypical antipsychotic medication use: a population-based cohort study. JAMA Intern Med 2015;175:450–2.
Drici MD, Priori S. Cardiovascular risks of atypical antipsychotic drug treatment. Pharmacoepidemiol Drug Saf 2007; 16:882–90.
Dubljanin-Raspopović E, Marković-Denic L, Ivković K, et al. The impact of postoperative pain on early ambulation after hip fracture. Acta Chir Iugosl 2013; 60:61–4.
Voeten SC, Krijnen P, Voeten DM, et al. Quality indicators for hip fracture care, a systematic review. Osteoporos Int 2018;29:1963–85.
Lindestrand AG, Christiansen ML, Jantzen C, et al. Opioids in hip fracture patients: an analysis of mortality and post hospital opioid use. Injury 2015;46:1341–5.
Calcaterra SL, Yamashita TE, Min SJ, et al. Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use. J Gen Intern Med 2016;31:478–85.
Von Korff M, Kolodny A, Deyo RA, et al. Long-term opioid therapy reconsidered. Ann Intern Med 2011; 155:325–8.
Sanzone AG. Current Challenges in Pain Management in Hip Fracture Patients. J Orthop Trauma 2016;30 Suppl 1:S1–5.
Kantor ED, Rehm CD, Haas JS, et al. Trends in Prescription Drug Use Among Adults in the United States From 1999–2012. JAMA 2015;314:1818–31.
Oderda LH, Young JR, Asche CV, et al. Psychotropic-related hip fractures: metaanalysis of first-generation and second-generation antidepressant and antipsychotic drugs. Ann Pharmacother 2012;46:917–28.
Yu NW, Chen PJ, Tsai HJ, et al. Association of benzodiazepine and Z-drug use with the risk of hospitalisation for fall-related injuries among older people: a nationwide nested case-control study in Taiwan. BMC Geriatr 2017; 17:140.
Johnell K, Jonasdottir Bergman G, Fastbom J, et al. Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults. Int J Geriatr Psychiatry 2017;32:414–420.
Kaukonen JP, Lüthje P, Nurmi-Lüthje I, et al. Second hip fracture and patients’ medication after the first hip fracture: a follow-up of 221 hip fracture patients in Finland. Arch Gerontol Geriatr 2011;52:185–9.
Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40,373–83.
WHO Collaboration Center for Drug Statistics and Methodology. ATC classification index with DDDs, 2019. Oslo, Norway 2018. Available at: https://www.whocc.no/atc_ddd_index/ [Accessed March, 2019].
Conflicts of interest: The authors have no financial or personal conflicts to disclose.
Ethical Standards: All identification numbers for all of the entries in the NHRID were encrypted to protect the privacy of individual patient. The study protocol was approved by the Research Ethics Committee of National Taiwan University Hospital (National Taiwan University Hospital Research Ethics Committee No. 201403069W).
Electronic supplementary material
About this article
Cite this article
Peng, LN., Chou, YJ., Chen, LK. et al. Post-Acute Use of Opioids and Psychotropics in Patients after Hip Fracture: Unintended Consequences of Implementing Diagnosis-Related Grouping Payment. J Nutr Health Aging 24, 745–751 (2020). https://doi.org/10.1007/s12603-020-1383-7
- Hip fracture
- diagnosis-related grouping (DRG) payment